跳至主要内容
临床试验/NCT03684395
NCT03684395已完成不适用

Association Between Socioeconomic Factors and Use of Direct Oral Anticoagulants Versus Standard of Care (Warfarin) in Patients With Non-valvular Atrial Fibrillation in Sweden

Bayer0 个研究点目标入组 68,056 人开始时间: 2016年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
68,056
主要终点
Correlation between socioeconomic factors and use of DOACs vs. Warfarin (as identified from the LISA database before the index date)

研究概览

简要总结

The healthcare system in Sweden is publicly funded and aims to provide equal access to care irrespective of socioeconomic status. This includes ensuring equity in drug treatment. Socioeconomic disparities have been shown to influence patient management and health outcomes in certain Swedish populations. The Swedish Board of Health and Welfare has stated that the prescription of new drugs, which are more expensive than generic standard of care drugs, might be influenced by patients' socioeconomic status.

To evaluate the association between socioeconomic factors and use of a DOAC (rivaroxaban, dabigatran, or apixaban) or standard of care (warfarin) in patients with NVAF in Sweden.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged ≥18 years in Sweden with a diagnosis of NVAF (identified using International Classification of Diseases, version 10 [ICD-10]) codes in the National Patient Register) between 1 December 2011 and 31 December 2014 and with a first dispensed prescription for either a DOAC or warfarin following their NVAF diagnosis.

排除标准

  • Patients with a dispensed prescription for a DOAC or warfarin prior to the index date (the date of first DOAC/warfarin purchase designated the index date)
  • Patients with a dispensed prescription for more than one anticoagulant at index date.
  • Patients with valvular atrial fibrillation

研究组 & 干预措施

Standard of care

干预措施: Standard of care (Warfarin) (Drug)

结局指标

主要结局

Correlation between socioeconomic factors and use of DOACs vs. Warfarin (as identified from the LISA database before the index date)

时间窗: approximately 3 years

Between 1 December 2011 and 31 December 2014; Socioeconomic factors: * Occupation * Education * Income * Family status * Immigrant status

次要结局

  • Secular trends in the correlation between socioeconomic factors and use of DOACs (vs. warfarin) - Trends based on the date of prescription by year(approximately 3 years)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验